To assess the effectiveness of PuraPly™AM in real-world clinical settings, as measured by: Percent reduction in wound area, time to complete wound closure (if closure occurs), and improvement in wound bed condition.
Principal Investigator: Damien Dauphinee, DPM
Locations: Baylor Scott & White The Heart Hospital – Denton
IRB Number: 017-486
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: None
Real-World Effectiveness Study of PuraPly™AM on Wounds (The RESPOND Registry)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.